Jul. 16 at 1:31 PM
$ABSI $GENB $ABCL
$ 400M at a $ 3.8B valuation?!?!
is this real or just over-hyped silicon valley BS?
“Today, we’re announcing new funding to accelerate our work at Chai:
$400 million at a
$3.8 billion valuation, from Index Ventures, Kleiner Perkins, Sequoia Capital, Dimension, and others.
In the past seven months since our Series B in December 2025, both our technical and commercial progress has accelerated. Our latest model, Chai-3, is unlocking targets that have long resisted traditional computational and laboratory methods, and turning them into tractable design problems. The world’s largest pharmaceutical companies—including Eli Lilly, Pfizer, and Novartis—have started adopting our models across their organizations.
We started Chai Discovery to build a future in which new medicines can be designed with the precision and speed of modern engineering. This funding will help us expand the compute, data, and research behind our models, accelerate product development, and bring…”
